Clinical Trials Browser

Phase 2 × Salivary Gland Neoplasms × Gonadotropin-Releasing Hormone × Clear all

NCT04325828 2026-02-13

YATAGARASU

Phase 2 Active not recruiting

31 enrolled 15 charts

Salivary Gland Neoplasms